-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Synthetic Route of (S,E)-4-(dimethylamino)-N-(4-oxo-7-((tetrahydrofuran-3-yl)oxy)-3,4-dihydroquinazolin-6-yl)but-2-enamide: An Overview of the Chemical Industry
Introduction
The synthesis of (S,E)-4-(dimethylamino)-N-(4-oxo-7-((tetrahydrofuran-3-yl)oxy)-3,4-dihydroquinazolin-6-yl)but-2-enamide is a complex and challenging process that involves several steps, including the synthesis of the tetrahydrofuran-3-yl ester, the condensation of the ester with the amino acid, the cyclization of the intermediate product, and the final deprotection of the amino group.
In this article, we will review the synthetic routes and methods used to synthesize (S,E)-4-(dimethylamino)-N-(4-oxo-7-((tetrahydrofuran-3-yl)oxy)-3,4-dihydroquinazolin-6-yl)but-2-enamide, which is an important compound in the field of medicine and pharmacology.
Synthetic Route 1: Via the Topfolding of the Tetrahydrofuran
The first synthetic route involves the topfolding of the tetrahydrofuran ring, which is a challenging and complex step.
The process involves the reaction of the tetrahydrofuran-3-yl ester with a strong acid, such as hydrochloric acid, in the presence of an alcohol, such as methanol or ethanol.
The reaction yields a mixture of the desired product and the corresponding alcohol, which must be separated from the reaction mixture.
Synthetic Route 2: Via the Condensation of the Tetrahydrofuran-3-yl Ester with the Amino Acid
The second synthetic route involves the condensation of the tetrahydrofuran-3-yl ester with the amino acid, which is reacted with the activated ester in the presence of a condensing agent, such as dicyclohexylcarbodiimide (DCC) or hydroxybenzotriazole (HOBT).
The reaction requires the presence of a solvent, such as dichloromethane or chloroform, and a base, such as pyridine or triethylamine.
The product is then isolated by chromatography or recrystallization.
Synthetic Route 3: Via the Cyclization of the Intermediate Product
The third synthetic route involves the cyclization of the intermediate product, which is formed by the condensation of the tetrahydrofuran-3-yl ester with the amino acid.
The process involves the reaction of the intermediate product with a strong acid, such as hydrochloric acid, in the presence of a water-soluble phase transfer catalyst, such as sodium hydroxide or potassium hydroxide.
The product is then isolated by filtration and washed with water.
Synthetic Route 4: Via the Final Deprotection of the Amino Group
The final synthetic route involves the deprotection of the amino group, which is protected by a tert-butyl group.
The process involves the reaction of the tert-butyl ester with a strong base, such as lithium hydroxide or sodium hydroxide, in the presence of a solvent, such as ether or THF.
The product is then isolated by filtration and washed with water.
Conclusion
The synthesis of (S,E)-4-(dimethylamino)-N-(4-oxo-7-((tetrahydrofuran-3-yl)oxy)-3,4-dihydroquinazolin-6-yl)